(Q37091883)

18 August 2017

1 reference

title

Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview (English)

1 reference

18 August 2017

3

Gustavo Turecki

1 reference

18 August 2017

Marcelo T Berlim

1

1 reference

18 August 2017

Marcelo P Fleck

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

40

1 reference

18 August 2017

2

1 reference

18 August 2017

149-159

1 reference

Definition and epidemiology of treatment-resistant depression

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Treatment-refractory depression: Definitions and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Treatment resistant depression: methodological overview and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Is treatment-resistant depression a unique subtype of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Research issues in the study of difficult-to-treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Challenges in the treatment of depression with psychotic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Depressive subtypes and efficacy of antidepressive pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Pharmacologic management of difficult-to-treat depression in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Report by the ACNP Task Force on response and remission in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Medication options in the treatment of treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A critical overview of the pharmacologic management of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Delusional unipolar depression: description and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A novel augmentation strategy for treating resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Can recovery from depression be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Deep brain stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701769728

10.1080/07853890701769728

21 January 2018

Identifiers

DOI

1 reference

release_corcrdmt5jcebnk6enkn27on3m

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/corcrdmt5jcebnk6enkn27on3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference